Embecta Corp (EMBC) stock news · P/E 4.3, rev $1.08B
Embecta Corp (EMBC) is a medical instruments & supplies company listed on US.
This EMBC news page leads with what Embecta Corp filed — not a scraped headline mill.
No cached 8-K sentence for EMBC yet. We will not pad this page with generic market recap.
Latest reported EMBC revenue for 2025-09-30 was $1.08B. Net income was $95.4M. Revenue was down 3.8% from 2024-09-30 to 2025-09-30. EMBC currently screens at market cap $609.6M and trailing P/E 4.3.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the EMBC stock page; for the tape open the quote page.
EMBC stock news FAQ
What are EMBC's latest revenue and net income?
Latest cached Embecta Corp (EMBC) revenue for Sep 30, 2025 was $1.08B. Net income was $95.4M. Statements: https://lician.com/financials/embc
How did EMBC revenue change from the prior cached period?
Cached Embecta Corp (EMBC) revenue was down 3.8% from $1.12B (Sep 30, 2024) to $1.08B (Sep 30, 2025). Statements: https://lician.com/financials/embc
What is EMBC's P/E ratio?
Embecta Corp (EMBC) trailing P/E is 4.27 on the latest cached fundamentals snapshot.
What is EMBC's market cap?
Embecta Corp (EMBC) market cap is $609.6M on the latest cached fundamentals snapshot.
What kind of company is EMBC?
Embecta Corp (EMBC) is a medical instruments & supplies company listed on US.
Where is EMBC stock news listed?
Cached stock news for Embecta Corp (EMBC) is listed at https://lician.com/news/embc. Filings: https://lician.com/sec/embc
Not investment advice.